2413.T

M3, Inc. [2413.T] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

2413.T Stock Summary

Earnings have grown 10.89% per last year.

Earnings are expected to fall -100% next year

Unstable dividend track record

2413.T has less than 1 year of cash runway

An RSI reading of 30 or below indicates an oversold or undervalued condition.

Top 10 Correlated ETFs

2413.T

Top 10 Correlated Stocks

2413.T

In the News

2413.T Financial details

Company Rating

Strong Buy

Market Cap

1344.1B

Income

46.36B

Revenue

234.85B

Book val./share

496.48

Cash/share

249.83

Dividend

Dividend %

0.79%

Employees

10.53K

Optionable

Shortable

Yes

Earnings

26 Apr 2024

P/E

33.89

Forward P/E

PEG

-12.36

P/S

7.01

P/B

4.94

P/C

7.14

P/FCF

34.1

Quick Ratio

2.63

Current Ratio

3.56

Debt / Equity

LT Debt / Equity

EPS (TTM)

68.28

EPS next Y

EPS next Q

EPS this Y

-23.22%

EPS next Y

EPS next 5Y

EPS last 5Y

19.03%

Revenue last 5Y

15.34%

Revenue Q/Q

8.55%

EPS Q/Q

20.14%

SMA20

-6.44%

SMA50

-11.26%

SMA100

-21.36%

Inst Own

Inst Trans

ROA

10%

ROE

16%

ROC

0.18%

Gross Margin

59%

Oper. Margin

30%

Profit Margin

21%

Payout

27%

Shs Outstand

Shs Float

Target Price

52W Range

1920.5-3474.0

52W High

-48.65%

52W Low

-7.08%

RSI

25.53

Rel Volume

1.1

Avg Volume

3.63M

Volume

Perf Week

-10.98%

Perf Month

-14.58%

Perf Quarter

-23.53%

Perf Half Y

-29.96%

Beta

0.744

Volatility

58.99%, 95.6%

Prev Close

-5.28%

Price

1784

Change

-5.16%

2413.T Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	174.52	193.05	249.31	306.67	339.99
Net income per share	30.22	31.89	55.73	94.06	72.22
Operating cash flow per share	27.4	39.49	68.7	76.77	84.13
Free cash flow per share	25.32	35.3	65.77	72.03	72.97
Cash per share	47.15	121.77	170.04	208.05	215.63
Book value per share	152.41	244.84	294.42	379.86	445.77
Tangible book value per share	70.1	147.75	193.6	266.73	290.86
Share holders equity per share	152.41	244.84	294.42	379.86	445.77
Interest debt per share	-7.64	3.83	5.47	4.39	4.92
Market cap	1208.17B	2167.66B	5138.17B	3033.42B	2241.01B
Enterprise value	1180.63B	2125.81B	5058.04B	2937.47B	2133.08B
P/E ratio	61.71	100.19	135.85	47.51	45.71
Price to sales ratio	10.69	16.55	30.37	14.57	9.71
POCF ratio	68.07	80.92	110.2	58.21	39.24
PFCF ratio	73.65	90.51	115.11	62.04	45.24
P/B Ratio	12.24	13.05	25.71	11.76	7.41
PTB ratio	12.24	13.05	25.71	11.76	7.41
EV to sales	10.44	16.23	29.89	14.11	9.24
Enterprise value over EBITDA	36.52	54.31	78.9	31.56	26.07
EV to operating cash flow	66.52	79.35	108.48	56.37	37.35
EV to free cash flow	71.97	88.76	113.31	60.08	43.06
Earnings yield	0.02	0.01	0.01	0.02	0.02
Free cash flow yield	0.01	0.01	0.01	0.02	0.02
Debt to equity	-0.05	0.02	0.02	0.01	0.01
Debt to assets	-0.04	0.01	0.01	0.01	0.01
Net debt to EBITDA	-0.85	-1.07	-1.25	-1.03	-1.32
Current ratio	2.29	3.19	3.26	3.48	3.42
Interest coverage	2.57K	880.44	522.27	1.83K	1.04K
Income quality	0.57	0.77	0.8	0.54	0.77
Dividend Yield	0	0	0	0	0
Payout ratio	0.17	0.21	0.15	0.13	0.22
Sales general and administrative to revenue	0.32	0.3	0.27	0.27	0.28
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.41	0.32	0.28	0.24	0.28
Capex to operating cash flow	-0.08	-0.11	-0.04	-0.06	-0.13
Capex to revenue	-0.01	-0.02	-0.01	-0.02	-0.03
Capex to depreciation	-0.97	-0.63	-0.35	-0.51	-1.02
Stock based compensation to revenue	0	0	0	0	0
Graham number	321.92	419.13	607.6	896.62	851.08
ROIC	0.23	0.14	0.2	0.25	0.16
Return on tangible assets	0.24	0.14	0.19	0.24	0.17
Graham Net	27.01	86.03	123	144.88	138.83
Working capital	35.99B	83.4B	113.8B	141.66B	143.89B
Tangible asset value	45.41B	100.24B	131.39B	181.05B	197.47B
Net current asset value	28.96B	71.31B	98.25B	116.85B	112.34B
Invested capital	-0.05	0.02	0.02	0.01	0.01
Average receivables	14.16B	30.97B	38.89B	47.56B	50.82B
Average payables	13.57B	15.91B	18.93B	24.77B	30.92B
Average inventory	751M	1.53B	1.6B	1.75B	1.91B
Days sales outstanding	91.41	93.68	95.25	89.38	80.13
Days payables outstanding	107.65	108.68	114.04	124.59	125.43
Days of inventory on hand	11.14	9.78	9.16	7.94	7.54
Receivables turnover	3.99	3.9	3.83	4.08	4.56
Payables turnover	3.39	3.36	3.2	2.93	2.91
Inventory turnover	32.77	37.31	39.83	45.99	48.42
ROE	0.2	0.13	0.19	0.25	0.16
Capex per share	-2.08	-4.19	-2.93	-4.74	-11.16

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q3

Metric	2022-12-31	2023-03-31	2023-06-30	2023-09-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	92.12	81.99	84.54	86.02	93.37
Net income per share	22.42	14.36	18.28	16.19	19.45
Operating cash flow per share	12.04	34.95	17.62	21.89	12.95
Free cash flow per share	9.85	29.38	12.7	18.88	9.85
Cash per share	198.43	215.62	238.73	247.73	249.83
Book value per share	428.26	445.75	466.65	488.44	496.48
Tangible book value per share	283.56	290.85	308.03	304.2	313.96
Share holders equity per share	428.26	445.75	466.65	488.44	496.48
Interest debt per share	0.38	4.85	0.1	0.14	0.59
Market cap	2429.1B	2241.11B	2110.77B	1843.99B	1584.06B
Enterprise value	2327.7B	2133.17B	2008.95B	1737.65B	1471.95B
P/E ratio	39.9	57.47	42.51	41.94	29.98
Price to sales ratio	38.84	40.26	36.78	31.58	24.99
POCF ratio	297.25	94.46	176.46	124.1	180.15
PFCF ratio	363.09	112.34	244.9	143.88	236.78
P/B Ratio	8.35	7.41	6.66	5.56	4.7
PTB ratio	8.35	7.41	6.66	5.56	4.7
EV to sales	37.22	38.32	35	29.75	23.22
Enterprise value over EBITDA	95.83	131.78	91.81	87.84	64.93
EV to operating cash flow	284.84	89.91	167.94	116.94	167.4
EV to free cash flow	347.94	106.93	233.08	135.58	220.02
Earnings yield	0.01	0	0.01	0.01	0.01
Free cash flow yield	0	0.01	0	0.01	0
Debt to equity	0	0.01	0	0	0
Debt to assets	0	0.01	0	0	0
Net debt to EBITDA	-4.17	-6.67	-4.65	-5.38	-4.95
Current ratio	3.66	3.42	3.85	3.56	3.95
Interest coverage	86.64	576.04	276.98	179.95	50.88
Income quality	0.37	1.69	0.6	0.85	0.44
Dividend Yield	0	0	0.01	0	0
Payout ratio	0	0	0.97	0.08	0
Sales general and administrative to revenue	0.26	0.32	0.31	0.32	0.29
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.28	0.28	0.27	0.3	0.3
Capex to operating cash flow	-0.18	-0.16	-0.28	-0.14	-0.24
Capex to revenue	-0.02	-0.07	-0.06	-0.03	-0.03
Capex to depreciation	-0.8	-1.8	-1.68	-0.93	-0.93
Stock based compensation to revenue	0	0	0	0	0
Graham number	464.77	379.5	438.16	421.81	466.16
ROIC	0.05	0.03	0.04	0.03	0.04
Return on tangible assets	0.06	0.03	0.04	0.03	0.04
Graham Net	137.28	138.83	129.32	135.09	143.54
Working capital	143.56B	143.89B	169.34B	163.43B	172.76B
Tangible asset value	192.51B	197.47B	209.13B	206.54B	213.17B
Net current asset value	114.08B	112.34B	117.94B	111.52B	118.56B
Invested capital	0	0.01	0	0	0
Average receivables	52.53B	53.24B	49.72B	50.63B	53.28B
Average payables	30.6B	31.91B	33.3B	34.87B	35.54B
Average inventory	0	987.5M	987.5M	0	0
Days sales outstanding	80.31	81.93	76.48	80.9	76.75
Days payables outstanding	112.29	126.2	133.41	133.86	124.52
Days of inventory on hand	0	7.58	0	0	0
Receivables turnover	1.12	1.1	1.18	1.11	1.17
Payables turnover	0.8	0.71	0.67	0.67	0.72
Inventory turnover	0	11.87	0	0	0
ROE	0.05	0.03	0.04	0.03	0.04
Capex per share	-2.18	-5.56	-4.92	-3.01	-3.1

2413.T Dividend History

2413.T Frequently Asked Questions

What is M3, Inc. stock symbol ?

M3, Inc. is a JP stock and trading under the symbol 2413.T

What is M3, Inc. stock quote today ?

M3, Inc. stock price is $1784 today.

Is M3, Inc. stock public?

Yes, M3, Inc. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 3.63M
Market Capitalization 1344.1B
Employee 10.53K
CEO Mr. Itaru Tanimura
Headquarters Tokyo,JP
IPO Date 2004-09-16
Website https://corporate.m3.com

M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. It operates m3.com, a members-only Web site for providing information to the healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; QOL-kun that provides life support information other than medical information to members; AskDoctors, where registered doctors answer questions about health and illness from the general public; MDLinx for medical professionals in the United States; and Doctorsnetuk, a website that provides developing services for pharmaceutical companies, as well as provides drug information database in France, Germany, and Spain. The company also provides career services for doctors and pharmacists through m3com CAREER. In addition, it engages in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; survey service for medical professionals; sale and marketing support businesses for pharmaceutical companies, etc. through the Internet; provision of management support and consulting services to medical institutions, and home-visit nursing services; and provision of human resources services for healthcare professionals, as well as operates clinical trial facilities. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.